Increase in adviser interest in EIS industry – FT Adviser

John Glencross, CEO, Calculus Capital was featured in an FT Adviser article looking into increased adviser interest in the EIS industry. EIS Industry claims steady increase in adviser interest FT Adviser 16/12/15 Statistics from enterprise investment scheme investment firms Deepbridge Capital … Continued

Calculus Capital’s reaction to the Finance Act 2015

John Glencross, CEO and Co-Founder, Calculus Capital sums up his thoughts on the Finance Act 2015 and how it will affect the EIS industry and Calculus Capital.“Our thoughts are that there is more complexity and that is unhelpful, but it does … Continued

Synpromics signs $1.5m up front contract with AGTC

We’re delighted to share that our portfolio company Synpromics has signed a contract with US based AGTC. For the full press release please see below.Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based … Continued

EIS funding rule changes to boost SMEs

Calculus Capital’s CEO John Glencross was quoted in Fund Strategy’s article on EIS funding changes. The government’s move to introduce increased flexibility for replacement capital within EIS and VCT schemes, as revealed in the Autumn Statement, has been welcomed by the industry … Continued

Calculus Capital invests in Once Upon A Time

Calculus Capital invests £2.5m in integrated marketing agency Once Upon A Time Once Upon A Time helps blue chip clients – such as Universal Pictures, Disney, Warner Bros, Lindt, Russian Standard Vodka, Hasbro and Pfizer deliver a continuous customer experience … Continued

Calculus Capital invests in IPV

Calculus Capital invests £2.5m in Cambridge firm at centre of global multi-media content revolution London, October 29. Private equity specialist Calculus Capital has invested £2.5m in a media technology business that provides multi-media content management systems to leading broadcasters and … Continued

Calculus Capital invests in Mologic

Calculus Capital invests £3m in developer of cutting-edge diagnostic technologies Private equity specialist Calculus Capital has made a multi-million-pound investment in Bedford-based Mologic, a developer of cutting-edge point-of-care diagnostic devices that help patients manage their own conditions. The £3m investment … Continued

Calculus Capital – Growth Investor Awards 2015

Calculus Capital has been named runner up for ‘Best EIS Investment Manager’ and ‘Growth Investor of the Year’ at the inaugural Growth Investor Awards, which recognises impact beyond investment in the UK SME finance industry. The Best EIS Investment Manager award, … Continued

Enterprise Investment Scheme

Madeleine Ingram, Calculus Capital, London, 25 August 2015. Calculus Capital is the focus of this article on how the UK’s Enterprise Investment Scheme landscape is shifting and where Calculus Capital sits in the new EIS market. By Tom … Continued